A new study finds an increased risk of venous thromboembolism (VTE) in the six months after starting testosterone replacement therapy compared to the six months before the therapy was initiated. The abstract says:
This case-crossover study analyzed data on 39 622 men from the IBM MarketScan...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.